These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 29072333)

  • 1. Large-scale purification of high purity α1-antitrypsin from Cohn Fraction IV with virus inactivation by solvent/detergent and dry-heat treatment.
    Huangfu C; Zhang J; Ma Y; Jia J; Li J; Lv M; Ma X; Zhao X; Zhang J
    Biotechnol Appl Biochem; 2018 May; 65(3):446-454. PubMed ID: 29072333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New process for purifying high purity α1-antitrypsin from Cohn Fraction IV by chromatography: A promising method for the better utilization of plasma.
    Huangfu C; Zhang J; Ma Y; Jia J; Lv M; Zhao X; Zhang J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Mar; 1046():156-164. PubMed ID: 28183045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of viruses by pasteurization at 60 °C for 10 h with and without 40% glucose as stabilizer during a new manufacturing process of α2-Macroglobulin from Cohn Fraction IV.
    Huangfu C; Ma Y; Jia J; Lv M; Zhu F; Ma X; Zhao X; Zhang J
    Biologicals; 2017 Mar; 46():139-142. PubMed ID: 28215695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of viruses during a new manufacturing process of α2-macroglobulin from Cohn Fraction IV by dry-heat treatment.
    Huangfu C; Zhao X; Lv M; Jia J; Zhu F; Wang R; Ma Y; Zhang J
    Transfusion; 2016 Sep; 56(9):2274-7. PubMed ID: 27383449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparable virus inactivation by bovine or vegetable derived Tween 80 during solvent/detergent treatment.
    Seitz H; Blümel J; Schmidt I; Willkommen H; Löwer J
    Biologicals; 2002 Sep; 30(3):197-205. PubMed ID: 12217344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enveloped virus inactivation by caprylate: a robust alternative to solvent-detergent treatment in plasma derived intermediates.
    Korneyeva M; Hotta J; Lebing W; Rosenthal RS; Franks L; Petteway SR
    Biologicals; 2002 Jun; 30(2):153-62. PubMed ID: 12127317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification of alpha 1 proteinase inhibitor from human plasma fraction IV-1 by ion exchange chromatography.
    Chen SX; Hammond DJ; Lang JM; Lebing WR
    Vox Sang; 1998; 74(4):232-41. PubMed ID: 9691404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dry-heat treatment process for enhancing viral safety of an antihemophilic factor VIII concentrate prepared from human plasma.
    Kim IS; Choi YW; Kang Y; Sung HM; Shin JS
    J Microbiol Biotechnol; 2008 May; 18(5):997-1003. PubMed ID: 18633304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virus reduction in the preparation of intravenous immune globulin: in vitro experiments.
    Chandra S; Cavanaugh JE; Lin CM; Pierre-Jerome C; Yerram N; Weeks R; Flanigan E; Feldman F
    Transfusion; 1999 Mar; 39(3):249-57. PubMed ID: 10204586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification and analysis of human alpha1-antitrypsin concentrate by a new immunoaffinity chromatography.
    Zhang X; Hou Y; Ding X; Ye S; Cao H; Wang Z; Du X; Xie YW; Li C
    Prep Biochem Biotechnol; 2014 Oct; 44(7):725-37. PubMed ID: 24279822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of viral safety of a high-purity human factor VIII concentrate submitted to 2 specific virus inactivation treatments (FANDHI)].
    Ristol P; Gensana M; Fernández J; Massot M; Biescas H; Darling A; Jorquera JI; Vericat F
    Sangre (Barc); 1996 Apr; 41(2):131-6. PubMed ID: 9045353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Directing membrane chromatography to manufacture α1-antitrypsin from human plasma fraction IV.
    Fan J; Luo J; Song W; Chen X; Wan Y
    J Chromatogr A; 2015 Dec; 1423():63-70. PubMed ID: 26518493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological Safety of a Highly Purified 10% Liquid Intravenous Immunoglobulin Preparation from Human Plasma.
    Goussen C; Simoneau S; Bérend S; Jehan-Kimmel C; Bellon A; Ducloux C; You B; Paolantonacci P; Ollivier M; Burlot L; Chtourou S; Flan B
    BioDrugs; 2017 Jun; 31(3):251-261. PubMed ID: 28508264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of eco-friendly zwitterionic detergents for enveloped virus inactivation.
    Conley L; Tao Y; Henry A; Koepf E; Cecchini D; Pieracci J; Ghose S
    Biotechnol Bioeng; 2017 Apr; 114(4):813-820. PubMed ID: 27800626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutaraldehyde inactivation of enveloped DNA viruses in the preparation of haemoglobin-based oxygen carriers.
    Ma H; Li Q; Feng K; Zhang Y; Zhu H; Chen C; Yan K
    Artif Cells Nanomed Biotechnol; 2018 Feb; 46(1):33-38. PubMed ID: 29081252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification of α2-macroglobulin from Cohn Fraction IV by immobilized metal affinity chromatography: A promising method for the better utilization of plasma.
    Huangfu C; Ma Y; Lv M; Jia J; Zhao X; Zhang J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jul; 1025():68-75. PubMed ID: 27214605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical and biological properties of an alpha 1-antitrypsin concentrate.
    Burnouf T; Constans J; Clerc A; Descamps J; Martinache L; Goudemand M
    Vox Sang; 1987; 52(4):291-7. PubMed ID: 3498260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preservation of red cell properties after virucidal phototreatment with dimethylmethylene blue.
    Wagner SJ; Skripchenko A; Robinette D; Mallory DA; Cincotta L
    Transfusion; 1998 Aug; 38(8):729-37. PubMed ID: 9709780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of "Nereid," a new phenol-free detergent to replace Triton X-100 in virus inactivation.
    Farcet JB; Kindermann J; Karbiener M; Scheinecker R; Kostner O; Kreil TR
    J Med Virol; 2021 Jun; 93(6):3880-3889. PubMed ID: 33274764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogen Safety of a New Intravenous Immune Globulin 10% Liquid.
    Radomski KU; Lattner G; Schmidt T; Römisch J
    BioDrugs; 2017 Apr; 31(2):125-134. PubMed ID: 28236170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.